Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.
Opsoclonus-myoclonus syndrome (OMS) is a rare acquired movement disorder occurring in all age groups, predominantly in infants. Although the exact pathogenesis is still undefined, there is strong evidence for a paraneoplastic or parainfectious immune process resulting in central nervous system dysfunction. Mycoplasma pneumoniae has been implicated in a number of immune-mediated neurologic diseases [28]. However, the association of M. pneumoniae and opsoclonus-myoclonus-ataxia syndrome is not well established so far. We present three cases with opsoclonus-myoclonus-ataxia syndrome in adolescents following an infection with M. pneumoniae. Monophasic disease course and full recovery correspond to the favorable prognosis known from parainfectious cases in young adults. This should affect therapeutic consideration. OMS should be added to the spectrum of M. pneumoniae-associated neurologic complications. Nevertheless, neuroblastoma has to be ruled out in all cases of OMS.
Department of Pediatrics, University Hospital, Inselspital, Bern, Switzerland.
Benedikt Maria
BM
Huber
Susi
S
Strozzi
Maja
M
Steinlin
Christoph
C
Aebi
Simon
S
Fluri
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification*; D053578:Opsoclonus-Myoclonus Syndrome / Q000175:diagnosis / Q000382:microbiology*; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone